Cargando…
Genomic profiling distinguishes familial multiple and sporadic multiple meningiomas
BACKGROUND: Meningiomas may occur either as familial tumors in two distinct disorders, familial multiple meningioma and neurofibromatosis 2 (NF2), or sporadically, as either single or multiple tumors in individuals with no family history. Meningiomas in NF2 and approximately 60% of sporadic meningio...
Autores principales: | Shen, Yiping, Nunes, Fabio, Stemmer-Rachamimov, Anat, James, Marianne, Mohapatra, Gayatry, Plotkin, Scott, Betensky, Rebecca A, Engler, David A, Roy, Jennifer, Ramesh, Vijaya, Gusella, James F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716362/ https://www.ncbi.nlm.nih.gov/pubmed/19589153 http://dx.doi.org/10.1186/1755-8794-2-42 |
Ejemplares similares
-
A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas
por: Beauchamp, Roberta L., et al.
Publicado: (2015) -
Bevacizumab Treatment for Meningiomas in NF2: A Retrospective Analysis of 15 Patients
por: Nunes, Fabio P., et al.
Publicado: (2013) -
Genomic profiling of sporadic multiple meningiomas
por: Erson-Omay, E. Zeynep, et al.
Publicado: (2022) -
Correction: Genomic profiling of sporadic multiple meningiomas
por: Erson-Omay, E. Zeynep, et al.
Publicado: (2022) -
Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2
por: Jordan, Justin T, et al.
Publicado: (2023)